The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Tech in AsiaAsia

NUHS, SingHealth join Cambridge-led AI blood test project

10.26

The BloodCounts! consortium won a 2021 Trinity Challenge prize for infectious-disease detection.

Read at Tech in Asia ↗

One letter a week, starting soon.

Latest

NUHS, SingHealth join Cambridge-led AI blood test project

More from Tech in Asia on Accept All

AsiaSG telehealth provider Care adopts Tencent Cloud’s RTC Tech in Asia

AsiaIndia’s Unacademy founders target $73.5m AI, deeptech fund Tech in Asia

AsiaSembcorp, Nxera explore low-carbon power for data centers Tech in Asia

AsiaHSBC launches AI tool for corporate banking clients Tech in Asia

AsiaSG insurtech firm Igloo to expand SaaS arm to MENA Tech in Asia

AsiaAI’s awful week is a peek into the future Tech in Asia